text_1: Cost effectiveness evaluations based on cRCT data accurately reflect prices for patients in actual clinical practice.
text_2: Only a minority of patients used the drugs long-term and daily (34.5% of conventional NSAIDs and 44.2% of coxibs), whereas coxib RCTs required daily use for at least 6-9 months.